Template:Erythrasma: Difference between revisions

Jump to navigation Jump to search
Kalsang Dolma (talk | contribs)
No edit summary
Irfan Dotani (talk | contribs)
No edit summary
Line 23: Line 23:
!
!
[[Erythrasma overview|Overview]]
[[Erythrasma overview|Overview]]
|-
!
|- bgcolor="Pink"
!
[[Erythrasma historical perspective|Historical Perspective]]
|-
!
|- bgcolor="Pink"
!
[[Erythrasma classification|Classification]]
|-  
|-  
!
!
Line 53: Line 65:
!
!
[[Erythrasma risk factors|Risk Factors]]
[[Erythrasma risk factors|Risk Factors]]
|-
!
|- bgcolor="Pink"
!
[[Erythrasma screening|Screening]]
|-  
|-  
!
!
Line 83: Line 101:
!
!
[[Erythrasma laboratory findings|Laboratory Findings]]
[[Erythrasma laboratory findings|Laboratory Findings]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Erythrasma electrocardiogram|Electrocardiogram]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Erythrasma x ray|X Ray]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Erythrasma CT|CT]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Erythrasma MRI|MRI]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Erythrasma echocardiography or ultrasound|Echocardiography or Ultrasound]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Erythrasma other imaging findings|Other Imaging Findings]]
|-  
|-  
!
!
Line 101: Line 155:
!
!
[[Erythrasma medical therapy|Medical Therapy]]
[[Erythrasma medical therapy|Medical Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Erythrasma surgery|Surgery]]
|-  
|-  
!
!
Line 107: Line 167:
!
!
[[Erythrasma primary prevention|Primary Prevention]]
[[Erythrasma primary prevention|Primary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Erythrasma secondary prevention|Secondary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Erythrasma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Erythrasma Future or Investigational Therapies|Future or Investigational Therapies]]
|-  
|-  
!
!

Revision as of 19:46, 2 August 2016